Literature DB >> 19279089

The marmoset model of GB virus B infections: adaptation to host phenotypic variation.

Trudie Weatherford1, Deborah Chavez, Kathleen M Brasky, Robert E Lanford.   

Abstract

Worldwide, approximately 170 million people are chronically infected with hepatitis C virus (HCV), and chronic infection frequently progresses to serious liver disease, including cirrhosis and hepatocellular carcinoma. GB virus B (GBV-B), the virus phylogenetically most closely related to HCV, causes hepatitis in tamarins. We have demonstrated the suitability of the tamarin as a host for GBV-B and as a surrogate nonhuman primate model for HCV infection, and we have initiated studies of GBV-B infection in a closely related species, the common marmoset (Callithrix jacchus). Here, we demonstrate that marmosets exhibit two phenotypes upon infection with GBV-B: the susceptible phenotype and the partially resistant phenotype. In addition, we identify changes that may correlate with adaptation of the virus to the partially resistant host. GBV-B was serially passaged five times through 14 marmosets as one lineage and two times through 6 marmosets as a second lineage. Virus adapted to the marmosets and eventually exhibited robust infections in two separate lineages, lineages 1 and 2. A third lineage was initiated with a molecular clone, and again, susceptible and partially resistant phenotypes were observed. Three isolates were fully sequenced (from lineage 1), and 21 nucleotide changes were observed, with six amino acid changes. We speculate that the marmoset partially resistant phenotype may be due to a polymorphism in the marmoset population that affects critical virus-host interactions and that wild-type GBV-B is capable of rapidly adapting to this altered host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279089      PMCID: PMC2681958          DOI: 10.1128/JVI.00033-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Mortality and hospital utilization for hepatocellular carcinoma in the United States.

Authors:  W Ray Kim; Gregory J Gores; Joanne T Benson; Terry M Therneau; L Joseph Melton
Journal:  Gastroenterology       Date:  2005-08       Impact factor: 22.682

2.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

3.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent.

Authors:  J Bukh; C L Apgar; M Yanagi
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

5.  A chimeric GB virus B with 5' nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins.

Authors:  Rene Rijnbrand; Yan Yang; Lucy Beales; Francis Bodola; Kathryn Goettge; Lisette Cohen; Robert E Lanford; Stanley M Lemon; Annette Martin
Journal:  Hepatology       Date:  2005-05       Impact factor: 17.425

6.  Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein.

Authors:  Karen K Kyuregyan; Valentina F Poleschuk; Natalya A Zamyatina; Olga V Isaeva; Michail I Michailov; Stefan Ross; Jens Bukh; Michael Roggendorf; Sergei Viazov
Journal:  Virus Res       Date:  2005-07-28       Impact factor: 3.303

7.  Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier.

Authors:  Fuan Wang; Yiyue Ma; John W Barrett; Xiujuan Gao; Joy Loh; Erik Barton; Herbert W Virgin; Grant McFadden
Journal:  Nat Immunol       Date:  2004-10-24       Impact factor: 25.606

Review 8.  Natural history of hepatitis C.

Authors:  David L Thomas; Leonard B Seeff
Journal:  Clin Liver Dis       Date:  2005-08       Impact factor: 6.126

9.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 10.  Evasion of intracellular host defence by hepatitis C virus.

Authors:  Michael Gale; Eileen M Foy
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

View more
  12 in total

1.  Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.

Authors:  Cordelia Manickam; Premeela Rajakumar; Lynn Wachtman; Joshua A Kramer; Amanda J Martinot; Valerie Varner; Luis D Giavedoni; R Keith Reeves
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

2.  Comparative genome analysis of the major histocompatibility complex (MHC) class I B/C segments in primates elucidated by genomic sequencing in common marmoset (Callithrix jacchus).

Authors:  Takashi Shiina; Azumi Kono; Nico Westphal; Shingo Suzuki; Kazuyoshi Hosomichi; Yuki F Kita; Christian Roos; Hidetoshi Inoko; Lutz Walter
Journal:  Immunogenetics       Date:  2011-04-20       Impact factor: 2.846

3.  Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck.

Authors:  Trudie Weatherford; Deborah Chavez; Kathleen M Brasky; Stanley M Lemon; Annette Martin; Robert E Lanford
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

4.  Antiviral activity and host gene induction by tamarin and marmoset interferon-alpha and interferon-gamma in the GBV-B primary hepatocyte culture model.

Authors:  Deborah Chavez; Bernadette Guerra; Robert E Lanford
Journal:  Virology       Date:  2009-06-07       Impact factor: 3.616

5.  Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.

Authors:  Caroline Marnata; Aure Saulnier; Dimitri Mompelat; Thomas Krey; Lisette Cohen; Célia Boukadida; Lucile Warter; Judith Fresquet; Ieva Vasiliauskaite; Nicolas Escriou; François-Loïc Cosset; Felix A Rey; Robert E Lanford; Peter Karayiannis; Nicola J Rose; Dimitri Lavillette; Annette Martin
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

6.  Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates.

Authors:  Zhao Zhang; Jun Liu; Meng Li; Hui Yang; Chiyu Zhang
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  A small nonhuman primate model for filovirus-induced disease.

Authors:  Ricardo Carrion; Youngtae Ro; Kareema Hoosien; Anysha Ticer; Kathy Brasky; Melissa de la Garza; Keith Mansfield; Jean L Patterson
Journal:  Virology       Date:  2011-09-28       Impact factor: 3.616

8.  HCV animal models: a journey of more than 30 years.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Viruses       Date:  2009-09-02       Impact factor: 5.048

9.  Long-Term Persistent GBV-B Infection and Development of a Chronic and Progressive Hepatitis C-Like Disease in Marmosets.

Authors:  Yuki Iwasaki; Ken-Ichi Mori; Koji Ishii; Noboru Maki; Sayuki Iijima; Tomoyuki Yoshida; Sachi Okabayashi; Yuko Katakai; Young-Jung Lee; Akatsuki Saito; Hiromi Fukai; Nobuyuki Kimura; Naohide Ageyama; Sayaka Yoshizaki; Tetsuro Suzuki; Yasuhiro Yasutomi; Tatsuo Miyamura; Mari Kannagi; Hirofumi Akari
Journal:  Front Microbiol       Date:  2011-12-07       Impact factor: 5.640

10.  Convergent evolution of escape from hepaciviral antagonism in primates.

Authors:  Maulik R Patel; Yueh-Ming Loo; Stacy M Horner; Michael Gale; Harmit S Malik
Journal:  PLoS Biol       Date:  2012-03-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.